Patient-centricity is increasingly at the heart of UK pharma and healthcare research. Quantitative methods allow experienced researchers to capture patient experiences, preferences, and outcomes, informing clinical strategies, market access, and commercial decision-making. Measuring Patient Preferences Discrete choice experiments (DCEs), conjoint analysis, and rating scales help quantify how patients value treatment attributes such […]
Category Archives: UK Pharma & Healthcare Quant Research: Advanced Insights
Digital Transformation in UK Quantitative Market Research
The UK pharma and healthcare sector is undergoing rapid digital transformation, and quantitative research is no exception. Emerging technologies, automation, and data-driven platforms are reshaping how researchers collect, analyse, and communicate insights. Automation in Data Collection and Analysis Digital platforms enable automated survey distribution, data cleaning, and preliminary analysis. This reduces manual effort […]
HEOR and Market Access: The Quant Researcher’s Role in the UK
Health Economics and Outcomes Research (HEOR) is central to demonstrating the value of therapies in the UK pharmaceutical market. Quantitative researchers play a pivotal role in generating the data and insights that underpin reimbursement, pricing, and market access decisions, particularly in the context of NICE and NHS evaluation. Understanding the UK Market Context […]
Communicating Complex Quant Insights to Stakeholders
In UK pharma and healthcare market research, quantitative analysis provides the evidence base for critical decisions. Yet even the most sophisticated models and datasets lose value if stakeholders cannot understand—or act on—the findings. For experienced quant researchers, communication is as important as statistical rigour. Knowing Your Audience Different stakeholders have different priorities. Clinicians […]
The Integration of RWD in UK Quantitative Market Research
Real-world data (RWD) is transforming the landscape of quantitative market research in UK pharma and healthcare. By harnessing the wealth of information from NHS records, patient registries, claims data, and digital health sources, quant researchers can generate more relevant, evidence-based insights that align with clinical realities and payer expectations. The Growing Importance of RWD […]
Evolving Quantitative Techniques in UK Pharma Research
The UK pharmaceutical and healthcare market research sector has long been at the forefront of quantitative research. As the industry becomes increasingly data-driven, researchers must adapt to evolving methodologies that deliver deeper, more actionable insights. For experienced quant researchers, staying ahead means mastering advanced techniques while aligning with the UK’s unique healthcare and regulatory environment. […]